APA (7th ed.) Citation

Olafsson, S., Löve, T. J., Fridriksdottir, R. H., Tyrfingsson, T., Runarsdottir, V., Hansdottir, I., . . . Gottfredsson, M. (2020). SAT344 - No restrictions should be placed on future treatment for patients who discontinue DAAs on their first or second attempt. A real world experience from the TraP HepC initiative in Iceland. Journal of Hepatology, 73, S827. https://doi.org/10.1016/S0168-8278(20)32095-X

Chicago Style (17th ed.) Citation

Olafsson, Sigurdur, et al. "SAT344 - No Restrictions Should Be Placed on Future Treatment for Patients Who Discontinue DAAs on Their First or Second Attempt. A Real World Experience from the TraP HepC Initiative in Iceland." Journal of Hepatology 73 (2020): S827. https://doi.org/10.1016/S0168-8278(20)32095-X.

MLA (9th ed.) Citation

Olafsson, Sigurdur, et al. "SAT344 - No Restrictions Should Be Placed on Future Treatment for Patients Who Discontinue DAAs on Their First or Second Attempt. A Real World Experience from the TraP HepC Initiative in Iceland." Journal of Hepatology, vol. 73, 2020, p. S827, https://doi.org/10.1016/S0168-8278(20)32095-X.